NEW YORK (GenomeWeb News) – CombiMatrix today reported that its second quarter revenues rose 15 percent, driven by 152 percent growth in revenues generated by its prenatal microarray testing services.
Registering provides access to this and other free content.
Already have an account?Login Now.
The NIH has issued a preliminary guidance for newborn dried blood spot research.
Wired writes that CRISPR could change the world — in many imaginative ways — and whether it will be for the better is still in the air.
In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.
In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.